Axis-Shield said that the new test under development is potentially applicable to a wide range of instruments currently used in the clinical laboratory unlike existing testing methods which require complex separation technology and denaturing solvents, making the tests difficult to operate on common clinical testing instruments.
The new approach covered in the filed application addresses the need for easier and more precise methodology and utilises custom-engineered antibodies to identify specific and relevant vitamin D when complexed with a carrier protein.
Axis-Shield chief executive officer Ian Gilham said that they are very pleased to have identified a new widely applicable technique for the measurement of vitamin D and to have filed a patent application covering this innovative approach.
“We look forward to developing commercial assays which have the potential to transform ways of accurately measuring blood levels of this very important vitamin and to offer these to our partners supplying high throughput laboratory analysers,” Gilham said.
